| Full Name | Invision |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 115 Roanoke Blvd, Salem, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073545539 | NPI | - | NPPES |
| 461360 | Other | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Jonathan Gudeman |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1760477228 PECOS PAC ID: 6002825171 Enrollment ID: I20060418000489 |
News Archive
People show impaired memory after receiving low intensity electrical stimulation administered to the frontal part of the brain by a commercial, freely available, device. Psychologists Laura Steenbergen and Lorenza Colzato, with their colleagues at the Leiden Institute of Brain and Cognition and fellow researchers from the Max Planck Institute on Human Development, published their findings in Experimental Brain Research.
Gilead Sciences, Inc. today announced that the Anti-Infective Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has recommended that aztreonam for inhalation solution be approved for the treatment of infections due to Pseudomonas aeruginosa (P. aeruginosa) in patients with cystic fibrosis (CF).
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rivastigmine transdermal system patches, 4.6 mg/24 hr and 9.5 mg/24 hr.
Isogenica Ltd today announced the opening of a new automation facility at their current location, Chesterford Research Park.
› Verified 4 days ago
| Provider Name | William S Mann |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1821036104 PECOS PAC ID: 4688683758 Enrollment ID: I20060418000536 |
News Archive
People show impaired memory after receiving low intensity electrical stimulation administered to the frontal part of the brain by a commercial, freely available, device. Psychologists Laura Steenbergen and Lorenza Colzato, with their colleagues at the Leiden Institute of Brain and Cognition and fellow researchers from the Max Planck Institute on Human Development, published their findings in Experimental Brain Research.
Gilead Sciences, Inc. today announced that the Anti-Infective Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has recommended that aztreonam for inhalation solution be approved for the treatment of infections due to Pseudomonas aeruginosa (P. aeruginosa) in patients with cystic fibrosis (CF).
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rivastigmine transdermal system patches, 4.6 mg/24 hr and 9.5 mg/24 hr.
Isogenica Ltd today announced the opening of a new automation facility at their current location, Chesterford Research Park.
› Verified 4 days ago
| Provider Name | Timothy Poling |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1013353390 PECOS PAC ID: 5698013183 Enrollment ID: I20190207001606 |
News Archive
People show impaired memory after receiving low intensity electrical stimulation administered to the frontal part of the brain by a commercial, freely available, device. Psychologists Laura Steenbergen and Lorenza Colzato, with their colleagues at the Leiden Institute of Brain and Cognition and fellow researchers from the Max Planck Institute on Human Development, published their findings in Experimental Brain Research.
Gilead Sciences, Inc. today announced that the Anti-Infective Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has recommended that aztreonam for inhalation solution be approved for the treatment of infections due to Pseudomonas aeruginosa (P. aeruginosa) in patients with cystic fibrosis (CF).
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rivastigmine transdermal system patches, 4.6 mg/24 hr and 9.5 mg/24 hr.
Isogenica Ltd today announced the opening of a new automation facility at their current location, Chesterford Research Park.
› Verified 4 days ago
| Provider Name | Katelyn Palmer |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1588224026 PECOS PAC ID: 5597095000 Enrollment ID: I20190926000997 |
News Archive
People show impaired memory after receiving low intensity electrical stimulation administered to the frontal part of the brain by a commercial, freely available, device. Psychologists Laura Steenbergen and Lorenza Colzato, with their colleagues at the Leiden Institute of Brain and Cognition and fellow researchers from the Max Planck Institute on Human Development, published their findings in Experimental Brain Research.
Gilead Sciences, Inc. today announced that the Anti-Infective Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has recommended that aztreonam for inhalation solution be approved for the treatment of infections due to Pseudomonas aeruginosa (P. aeruginosa) in patients with cystic fibrosis (CF).
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rivastigmine transdermal system patches, 4.6 mg/24 hr and 9.5 mg/24 hr.
Isogenica Ltd today announced the opening of a new automation facility at their current location, Chesterford Research Park.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Invision 115 Roanoke Blvd, Salem, VA 24153-4907 Ph: (540) 387-1183 | Invision 115 Roanoke Blvd, Salem, VA 24153-4907 Ph: (540) 387-1183 |
News Archive
People show impaired memory after receiving low intensity electrical stimulation administered to the frontal part of the brain by a commercial, freely available, device. Psychologists Laura Steenbergen and Lorenza Colzato, with their colleagues at the Leiden Institute of Brain and Cognition and fellow researchers from the Max Planck Institute on Human Development, published their findings in Experimental Brain Research.
Gilead Sciences, Inc. today announced that the Anti-Infective Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has recommended that aztreonam for inhalation solution be approved for the treatment of infections due to Pseudomonas aeruginosa (P. aeruginosa) in patients with cystic fibrosis (CF).
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rivastigmine transdermal system patches, 4.6 mg/24 hr and 9.5 mg/24 hr.
Isogenica Ltd today announced the opening of a new automation facility at their current location, Chesterford Research Park.
› Verified 4 days ago
Dr. Alicia Marie Brown, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1970 Roanoke Blvd, Salem, VA 24153 Phone: 540-985-2463 Fax: 540-224-1922 | |
Gary L. Best O.d. Family Eye Care P.c. Optometrist Medicare: Medicare Enrolled Practice Location: 904 Apperson Dr, Salem, VA 24153 Phone: 540-389-0731 Fax: 540-389-1192 | |
Dr. Scott Alan Depoe, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1970 Roanoke Blvd, Salem, VA 24153 Phone: 540-982-2463 Fax: 540-224-1922 | |
Dr. Timothy Garland Jessee, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1851 W Main St, Salem, VA 24153 Phone: 540-375-3937 Fax: 540-387-4219 | |
Curtis Deon Burnley Jr., Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1970 Roanoke Blvd, Salem, VA 24153 Phone: 540-982-2463 | |
Dr. Daniel Richard Eckermann, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1970 Roanoke Blvd, Salem, VA 24153 Phone: 540-982-2463 Fax: 540-224-1922 |